Journal: Advanced Science
Article Title: Amyloid β Instigates Cardiac Neurotrophic Signaling Impairment, Driving Alzheimer's Associated Heart Disease
doi: 10.1002/advs.202511924
Figure Lengend Snippet: Alzheimer's disease pathology negatively impacts the neuro‐signaling pathway in the brain/heart axis of Tg2576 mice. (A,B): Representative immunoblots (A) and densitometric analysis (B) showing levels of NGF (n=5 vs. n=5, Student's t‐test P value 0.0023; Holm Sidak adjusted P value 0.0092), BDNF (n=5 vs. n=5, Student's t‐test P value 0.0250; Holm Sidak adjusted P value 0.0731), GAP‐43 (n=5 vs. n=4, Student's t‐test P value 0.0531; Holm Sidak adjusted P value 0.0531), and dβh (n=5 vs. n=5, Student's t‐test P value 0.0490; Holm Sidak adjusted P value 0.0956), in total heart tissue. In cerebral cortex lysates, NGF (n=5 vs. n=5, Student's t‐test P value 0.0034; Holm Sidak adjusted P value 0.0135), BDNF (n=3 vs. n=3, Student's t‐test P value 0.0069; Holm Sidak adjusted P value 0.0206), GAP‐43 (n=4 vs. n=4), and dβh (n=3 vs. n=4, Student's t‐test P value 0.0696; Holm Sidak adjusted P value 0.1343), from WT and Tg2576 mice. GAPDH levels were used as a loading control. (C–E): Digital images (C, scale bar 100 µm) and quantifications (D,E) showing cardiac adrenergic nerve fibers, labeled with anti‐tyrosine‐hydroxylase (TH, in green) (D), (n=4 vs. n=4, Student's t‐test P value 0.0060), and cardiac regenerating nerve endings, labeled with anti‐neuronal regeneration marker (GAP‐43, in red) (E), (n=4 vs. n=4, Student's t‐test P value 0.0170), in cardiac sections from WT and Tg2576 mice. Data are presented as a mean±SEM.
Article Snippet: Total lysates were used to evaluate the protein levels of NGF (Alomone labs, AN‐240; 1:1000), BDNF (Alomone labs, ANT‐010; 1:1000), GAP‐43 (Millipore, #AB552; 1:1000), Cleaved Caspase‐3‐ Asp175 (Cl‐Casp‐3, Cell Signaling, #94530; 1:500), dopamine β hydroxylase (DβH, Millipore, #AB1536; 1:1000), human Aβ [mouse monoclonal anti‐Aβ antibodies mixture composed of 4G8 epitope (residues Aβ18‐22, Covance, SIG‐39320; 1:1000) and 6E10 epitope (residues Aβ3‐8, Covance, SIG‐39220; 1:1000)], serum amyloid A3 (SAA3, Abcam, #ab231680; 1:500), TrkB [p Tyr816] (Novus Bio, #NBP1‐03499SS; 1:1000), TrkB (80E3) (Cell Signaling, #4603; 1:1000), phospho‐CREB (Ser133) (1B6) (Cell Signaling, #9196; 1:1000), CREB (Cell Signaling, #9197; 1:1000), p75NTR (Sigma Aldrich, 07‐476; 1:1000), fibronectin (Abcam, #ab2413; 1:1000), matrix metalloproteinases‐ 2 (MMP‐2, Cell Signaling, #35814; 1:1000), Laminin A/C (Santa Cruz Biotechnology, sc‐376248; 1:500), Actin (Millipore, MAB1501; 1:1000) and GAPDH (Santa Cruz Biotechnology, sc‐32233,6C5; 1: 2000), the three latter of which were used as loading controls.
Techniques: Western Blot, Control, Labeling, Marker